Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19
Carmelo Carmona-Rivera, … , Luigi D. Notarangelo, Mariana J. Kaplan
Carmelo Carmona-Rivera, … , Luigi D. Notarangelo, Mariana J. Kaplan
Published July 19, 2022
Citation Information: JCI Insight. 2022;7(16):e160332. https://doi.org/10.1172/jci.insight.160332.
View: Text | PDF
Research Article Infectious disease Inflammation

Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19

  • Text
  • PDF
Abstract

Dysregulation in neutrophil extracellular trap (NET) formation and degradation may play a role in the pathogenesis and severity of COVID-19; however, its role in the pediatric manifestations of this disease, including multisystem inflammatory syndrome in children (MIS-C) and chilblain-like lesions (CLLs), otherwise known as “COVID toes,” remains unclear. Studying multinational cohorts, we found that, in CLLs, NETs were significantly increased in serum and skin. There was geographic variability in the prevalence of increased NETs in MIS-C, in association with disease severity. MIS-C and CLL serum samples displayed decreased NET degradation ability, in association with C1q and G-actin or anti-NET antibodies, respectively, but not with genetic variants of DNases. In adult COVID-19, persistent elevations in NETs after disease diagnosis were detected but did not occur in asymptomatic infection. COVID-19–affected adults displayed significant prevalence of impaired NET degradation, in association with anti-DNase1L3, G-actin, and specific disease manifestations, but not with genetic variants of DNases. NETs were detected in many organs of adult patients who died from COVID-19 complications. Infection with the Omicron variant was associated with decreased NET levels when compared with other SARS-CoV-2 strains. These data support a role for NETs in the pathogenesis and severity of COVID-19 in pediatric and adult patients.

Authors

Carmelo Carmona-Rivera, Yu Zhang, Kerry Dobbs, Tovah E. Markowitz, Clifton L. Dalgard, Andrew J. Oler, Dillon R. Claybaugh, Deborah Draper, Meng Truong, Ottavia M. Delmonte, Francesco Licciardi, Ugo Ramenghi, Nicoletta Crescenzio, Luisa Imberti, Alessandra Sottini, Virginia Quaresima, Chiara Fiorini, Valentina Discepolo, Andrea Lo Vecchio, Alfredo Guarino, Luca Pierri, Andrea Catzola, Andrea Biondi, Paolo Bonfanti, Maria C. Poli Harlowe, Yasmin Espinosa, Camila Astudillo, Emma Rey-Jurado, Cecilia Vial, Javiera de la Cruz, Ricardo Gonzalez, Cecilia Pinera, Jacqueline W. Mays, Ashley Ng, Andrew Platt, NIH COVID Autopsy Consortium, COVID STORM Clinicians, Beth Drolet, John Moon, Edward W. Cowen, Heather Kenney, Sarah E. Weber, Riccardo Castagnoli, Mary Magliocco, Michael A. Stack, Gina Montealegre, Karyl Barron, Danielle L. Fink, Douglas B. Kuhns, Stephen M. Hewitt, Lisa M. Arkin, Daniel S. Chertow, Helen C. Su, Luigi D. Notarangelo, Mariana J. Kaplan

×

Figure 7

Impairment in NET degradation correlates with comorbidities, and NETs are detected in pulmonary and extrapulmonary tissues in COVID-19.

Options: View larger image (or click on image) Download as PowerPoint
Impairment in NET degradation correlates with comorbidities, and NETs ar...
(A) Decreased serum NET degradation capabilities in patients with severe COVID-19 from Brescia, Italy (mild n = 17, moderate n = 8, severe n = 13, critical n = 89). Kruskal-Wallis analysis was used. Serum samples from COVID-19 patients with (B) pneumonia (absent n = 17, pneumonia n = 109), (C) neurological manifestations (absent n = 103, neurological n = 17), and (D) malignancy (absent n = 110, malignancy n = 17) displayed decreased capabilities of NET degradation. Results are the mean ± SEM. Mann-Whitney was used. (E) Representative confocal images of citH4 (red) and DNA (blue) detected in lung, heart, kidney, and spleen tissues obtained from postmortem COVID-19 patients (n = 13). Original magnification, ×20, ×40 (insets). (F) Summary of tissue NET detection in each patient (n = 13). (G) Pie charts depicting global NET detection per tissue analyzed. Red indicates positive to citH4 (NETs); black indicates no presence of citH4 signal (no NETs); *P < 0.05, **P < 0.01. RFU, relative fluorescence units.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts